Lantern Pharma's market cap is currently $46.70M. The company's EPS TTM is $-1.773; its P/E ratio is ―; Lantern Pharma is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -174.84K	$ -154.68K	$ -97.42K	$ -3.39K	$ -1.63K
Operating Income	$ -17.88M	$ -14.43M	$ -12.59M	$ -5.91M	$ -2.43M
EBITDA	$ -15.79M	$ -14.42M	$ -12.27M	$ -5.90M	$ -2.43M
Net Income	$ -15.96M	$ -14.09M	$ -12.30M	$ -5.91M	$ -2.43M
Balance Sheet
Cash & Short-Term Investments	$ 41.30M	$ 55.20M	$ 70.73M	$ 19.23M	$ 1.23M
Total Assets	$ 43.65M	$ 58.84M	$ 73.95M	$ 20.36M	$ 1.43M
Total Debt	$ 234.47K	$ 52.89K	$ 204.95K	$ 108.50K	$ 0.00
Net Debt	$ -21.70M	$ -37.15M	$ -51.32M	$ -19.12M	$ -1.23M
Total Liabilities	$ 2.74M	$ 2.80M	$ 2.38M	$ 660.84K	$ 489.29K
Stockholders' Equity	$ 40.91M	$ 56.04M	$ 71.57M	$ 19.70M	$ 943.28K
Cash Flow
Free Cash Flow	$ -14.37M	$ -12.80M	$ -10.61M	$ -5.67M	$ -2.13M
Operating Cash Flow	$ -14.35M	$ -12.77M	$ -10.59M	$ -5.65M	$ -2.13M
Investing Cash Flow	$ -930.21K	$ 179.27K	$ -19.53M	$ -16.14K	$ -5.72K
Financing Cash Flow	$ -500.00K	-	$ 63.42M	$ 23.66M	$ 2.92M

Currency in USD

Lantern Pharma Earnings and Revenue History

Income Statement >

Lantern Pharma Debt to Assets

Balance Sheet >

Lantern Pharma Cash Flow

Cash Flow >

Lantern Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing